Spotting or heavier flow that returns 12 months or more after your last period is always considered abnormal and warrants a prompt evaluation. Even a single streak of pink on the toilet paper counts, because the source cannot be judged by how light it looks. Most causes turn out to be benign, and only a small share link to endometrial cancer, but you cannot know which category your bleeding falls into without an evaluation.
The sections below walk through the most common causes of postmenopausal bleeding, the warning signs that call for faster action, the diagnostic pathway, and the treatment options that follow once a cause is identified.
Why Postmenopausal Bleeding Is Never Normal
Once your periods have stopped for a full year, the lining of the uterus should stay quiet. Any bleeding after that point means something has disrupted that stability, from fragile tissue to a growth to, in a minority of cases, cancer. Because the cause is unpredictable from the outside, evaluation is non-negotiable, even when the bleeding is light, brief, or painless.
Around 5 to 10 percent of women who present with postmenopausal bleeding are found to have endometrial cancer. That number is small enough to avoid panic and large enough to justify a prompt appointment, and the remaining 90 to 95 percent split across benign conditions that are usually straightforward to treat once identified.
The Most Common Causes and How They Differ
Endometrial atrophy leads the list, accounting for roughly three out of every four cases. Years without estrogen leave the uterine lining thin, dry, and prone to cracking, much like skin that bleeds after a minor scrape, and the bleeding is usually light and painless. Pink or brown discharge is more common than a red flow.
Non-Cancerous Structural Causes
Endometrial polyps and cervical polyps are soft, often pedunculated growths that protrude into the uterine cavity or cervical canal. They tend to cause spotting between periods or after intercourse, and they are almost always benign. Endometrial hyperplasia, a thickening of the uterine lining, sits in a middle zone: hyperplasia without atypical cells often responds to hormonal management, while atypical hyperplasia carries a meaningful risk of progressing to cancer and is treated more aggressively.
Hormonal and Medication-Related Bleeding
Hormone replacement therapy is a frequent culprit, especially in the first six months of use or after a dose change. Sequential regimens that include a progestin withdrawal bleed are different from unscheduled bleeding, which is what you need to report. Vaginal atrophy, sometimes called atrophic vaginitis, can also produce bleeding from fragile vulvar or vaginal tissue, often after sex or even a routine pelvic exam.
Cancer and Other Serious Causes
Endometrial cancer is the cause everyone worries about, and it is the reason the workup exists. Cervical cancer and, less often, ovarian or fallopian tube cancers can also present with bleeding, though they more commonly cause pain, pressure, or abnormal discharge first. Bleeding that recurs after a reassuring initial workup is a signal to push for a closer look, because some cancers are focal and easy to miss on a blind biopsy.
That small failure rate is exactly what makes the next set of red flags worth memorizing.
| Cause | Approximate Share of Cases | Typical Bleeding Pattern |
|---|---|---|
| Endometrial atrophy | ~75% | Light spotting, often painless |
| Endometrial or cervical polyps | 10–15% | Spotting, often post-coital |
| Endometrial hyperplasia | 5–10% | Variable, may be heavy |
| Endometrial cancer | 5–10% | Often heavy or persistent |
| Hormone replacement therapy | Variable | Light, related to dose changes |
| Vaginal atrophy | Variable | Light, often after sex or exam |
Warning Signs That Need Faster Action
Any bleeding after menopause deserves a call to your clinician, but certain patterns push that call up the priority list. Heavy bleeding that soaks a pad, bleeding that contains clots, or bleeding that lasts more than a few days should be reported the same day rather than at a routine visit.
Red Flags That Travel With Bleeding
Bleeding combined with pelvic pain, unexplained weight loss, persistent fatigue, or a change in bowel or bladder habits points toward a more serious process. New or worsening pain during intercourse and a watery or foul-smelling discharge can also signal an underlying problem. None of these symptoms rules cancer in or out on their own, but they raise the urgency of the workup.
Personal and Family History That Shift the Threshold
A personal history of polycystic ovary syndrome, late menopause, never having been pregnant, obesity, or tamoxifen use nudges your baseline risk upward. A family history of endometrial or colorectal cancer, especially Lynch syndrome, does the same. When these factors are present, many clinicians move straight to tissue sampling rather than starting with imaging alone, because early detection changes the treatment options dramatically.
Because the order of those tests shapes what the treatment plan can realistically offer.
Track the dates, color, and amount of any bleeding in a small notebook or phone note. That record often does more to speed up a diagnosis than any single test result.
How Doctors Diagnose the Cause
The workup follows a deliberate sequence designed to rule out the most dangerous cause first while sparing you unnecessary procedures. Most pathways begin with a pelvic exam, move to imaging, and then to tissue sampling only when the first two steps are inconclusive or concerning.
Pelvic Exam and Transvaginal Ultrasound
A pelvic exam lets the clinician see whether the bleeding is coming from the vagina, cervix, or higher in the uterus. A transvaginal ultrasound then measures the endometrial stripe, the thickness of the uterine lining on imaging. A stripe of 4 mm or less is generally considered reassuring and is often followed by a watchful wait or treatment for atrophy, while a stripe above 4 mm usually triggers a biopsy.
Tissue Sampling and Direct Visualization
An endometrial biopsy samples the lining through a thin catheter passed through the cervix. It is fast, office-based, and modestly uncomfortable, but it can miss focal lesions. Hysteroscopy, a procedure that uses a small camera to look directly inside the uterus, and sonohysterography, a saline-infusion ultrasound, fill in the gaps when a biopsy is non-diagnostic or symptoms persist despite a normal result.
| Step | What It Looks For | When It Is Used |
|---|---|---|
| Pelvic exam | Vaginal or cervical source | First visit for any bleeding |
| Transvaginal ultrasound | Endometrial thickness > 4 mm | After initial exam |
| Endometrial biopsy | Cancer or hyperplasia | Thick stripe or persistent bleeding |
| Hysteroscopy | Polyps or focal lesions | When biopsy is inconclusive |
| Sonohysterography | Subtle polyps or thickening | Alternative to hysteroscopy |
Treatment Options Based on the Underlying Cause
Treatment always follows the diagnosis, and the diagnosis is what the workup is designed to deliver. Once a cause is identified, your care team will tailor the next step to that finding, your overall health, and your preferences about future interventions.
Benign and Hormonal Causes
Endometrial atrophy is often managed with low-dose vaginal estrogen, moisturizers, or lubricants that restore tissue integrity. Polyps are typically removed during hysteroscopic polypectomy, a same-day procedure that both diagnoses and treats in one step. HRT-related bleeding usually responds to adjusting the dose, switching from oral to transdermal delivery, or modifying the progestin component rather than stopping therapy altogether.
Hyperplasia and Cancer
Endometrial hyperplasia without atypia may be treated with progestin therapy and repeat sampling, with the goal of reversing the thickening. Atypical hyperplasia and early-stage endometrial cancer often require hysterectomy, sometimes paired with staging surgery to check nearby lymph nodes. Advanced cancer may involve radiation, chemotherapy, or hormone therapy, with the plan shaped by the stage, your age, and your overall health.
Limits of Reassurance and When to Push for More
A single normal ultrasound or negative biopsy can be genuinely reassuring, but it is not the same as a closed case. Symptoms that persist, worsen, or recur after a clean workup deserve another look, and that is worth saying out loud because it is easy to accept the first reassuring result as final.
Some bleeding is labeled as atrophy without adequate imaging, which can miss a focal lesion sitting under a thin background lining. A short list of practical steps helps turn knowledge into action:
- Request a written summary of every diagnosis, the threshold for follow-up, and the date your next review is due.
- Ask for the endometrial thickness number from any ultrasound, not just a verbal “looks fine.”
- Re-present promptly if bleeding returns after a normal workup, because focal lesions can develop later.
- Keep cervical screening current and ask whether colorectal screening is overdue, since both can surface related findings.
- Bring a symptom timeline with dates, amounts, and triggers, and hand it to the clinician at the start of the visit.
Advocacy here is not about being difficult. It is about making sure the explanation you leave with matches the symptoms you brought in.
The Big Picture
A single drop of blood on the toilet paper months or years after periods have stopped is a red flag that something in the body needs attention. Most causes are treatable, the workup is well mapped, and early evaluation preserves every option. The single most useful habit you can build is treating any unexpected bleeding as worth a same-week conversation with your clinician, because the sooner the cause is named, the simpler the next step usually is.
FAQ
What causes bleeding after menopause?
The most common cause is endometrial atrophy, which accounts for roughly 75% of cases. Polyps, endometrial hyperplasia, vaginal atrophy, hormone replacement therapy, and, in 5–10% of cases, endometrial cancer round out the list.
How much bleeding after menopause is normal?
None. Even light spotting or a single streak of blood on the toilet paper is considered abnormal and warrants an evaluation, because the volume of bleeding does not predict its cause.
When should I be concerned about postmenopausal bleeding?
Concern rises with heavy bleeding, clots, bleeding that lasts more than a few days, or bleeding accompanied by pelvic pain, unexplained weight loss, or fatigue. Persistent or recurrent spotting after a reassuring workup is also worth re-reporting.
What tests are done for postmenopausal bleeding?
Most pathways begin with a pelvic exam and transvaginal ultrasound. If the endometrial stripe is above 4 mm or bleeding persists, an endometrial biopsy, hysteroscopy, or sonohysterography usually follows.
Can postmenopausal bleeding be harmless?
Yes, often. Endometrial atrophy, polyps, and HRT-related changes are common, benign, and typically easy to treat. The point of evaluation is to confirm which one you are dealing with and to rule out cancer.
What is the most common cause of postmenopausal bleeding?
Endometrial atrophy, the thinning and fragility of the uterine lining that comes from long-term estrogen deficiency, is the leading cause and accounts for about three of every four cases.
